Rare diseases
Investigational molecules
Locations
Study of Nadunolimab with Gemcitabine and Carboplatin for Patients with Advanced Triple Negative Breast Cancer
SpainStudy Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation
SpainStudy Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant
SpainStudy on the Safety and Effects of BNT314 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors
SpainStudy on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
SpainStudy on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
SpainStudy of Emrusolmin for Treating Adults with Multiple System Atrophy
SpainStudy of AFM24 and Atezolizumab for Patients with Advanced or Metastatic EGFR-expressing Cancers
SpainStudy on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients
SpainStudy on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease
SpainStudy Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma
SpainStudy of nivolumab, relatlimab and bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
